Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Operating Income
Amedisys Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Operating Income
$193.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
36%
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Amedisys Inc's Operating Income?
Operating Income
193.1m
USD
Based on the financial report for Dec 31, 2023, Amedisys Inc's Operating Income amounts to 193.1m USD.
What is Amedisys Inc's Operating Income growth rate?
Operating Income CAGR 10Y
36%
Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Amedisys Inc have been 1% over the past three years , 4% over the past five years , and 36% over the past ten years .